Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

261 results about "Arsenic trioxide" patented technology

Arsenic trioxide is used to treat a type of leukemia (acute promyelocytic leukemia-APL)..

Method for extracting high arsenic complicated golden ore concentrate multielement

The invention discloses a method for extracting high arsenic complicated golden ore concentrate multielement. The method comprises the following steps that: the multielement complicated golden ore concentrate with extra-high arsenic is subjected to the roast dearsenification technique treatment, part of sulfur in the multielement high arsenic golden ore concentrate converted into sulfur dioxide and the arsenic converted into arsenic trioxide enter flue gas which is subjected to dust and arsenic collection, and then enter an acid making system to produce sulphuric acid; the multielement smelting slag and multielement low arsenic golden ore concentrate obtained by roast dearsenification, return products and flux are mixed to obtain copper matte regulus, and the like by adopting oxygen enrichment bottom blowing matte smelting gold collecting process to carry out the smelting process; the copper matte regulus is subjected to converting and refining to cast an anode plate which is sent to an electrolysis system to obtain an electrolytic copper product by refining; anode mud generated through electrolysis is sent to a noble metal refine system to produce gold and sliver, and the like; smelting slag and converting slag are subjected to floatation treatment to obtain copper and iron ore concentrate; and the generated gangue belongs to harmless slag and can be used. The method has the characteristics of wide range of the raw material application, high synthesized recovery efficiency of valuable element, and obvious economic and environment benefits.
Owner:SHANDONG HUMON SMELTING

Method for preparing arsenic trioxide from arsenic sulfide waste

The invention provides a method for preparing arsenic trioxide from arsenic sulfide waste. The arsenic sulfide waste is soaked in a sodium hydroxide solution to extract arsenic sulfide, arsenic sulfide mixes with an excessive amount of arsenic acid, and the mixture reacts at a temperature ranging from 40 DEG C to 95 DEG C for 0.5 to 3 hours, to produce a mixture containing arsenous acid and elemental sulfur; the mixture containing arsenous acid and elemental sulfur mixes with 2 to 5 times (by mass) of water and then oxygen gas is introduced so that arsenous acid is oxidized into arsenic acid, and the reaction product is filtered to remove elemental sulfur and thus to produce an arsenic acid solution; and the arsenic acid solution is reduced by sulfur dioxide gas to arsenous acid with a lower solubility, the reaction liquid is distilled under a reduced pressure to produce a saturated solution of arsenous acid, the saturated solution of arsenous acid is cooled so that arsenous acid is crystallized and then filtered to produce a filter cake of arsenous acid, and the filter cake of arsenous acid is dried and pulverized to obtain an arsenic trioxide product. The method has a short process flow, increases the recovery rate of arsenic, avoids the production of secondary pollutants, adopts simple equipment, greatly reduces the cost of arsenic recovery and is worthy to be widely applied.
Owner:JIANGSU ZHONGKE MACHINERY

Cascade recovery method for arsenic-containing antimony-containing gold ore difficult to process

The invention provides a cascade recovery method for arsenic-containing antimony-containing gold ore difficult to process, and relates to a method for separating and extracting antimony, arsenic and gold of the gold ore difficult to process. The method is characterized in that the recovery process includes the steps that (1) sodium sulphide is added under the alkaline condition, and antimony leaching is carried out; (2) electrodeposition is conducted on leaching liquid to obtain cathode antimony liquid; (3) leaching residues are washed, and concentrated sulfuric acid is added into the washed liquid for antimony deposition; (4) the leaching residues are roasted for arsenic removal and desulfuration, so that pozzuolite enters smoke, the smoke is chilled and crystallized to recover arsenic trioxide, and acid making with smoke is achieved after arsenic recovery; and (5) gold and silver in the roasted residues are separated after antimony, arsenic and sulphur are extracted. The method is special for the arsenic-containing antimony-containing gold ore difficult to process, the influences of arsenic and antimony on the recovery rate of noble metal are effectively eliminated, the problem that arsenic and antimony are difficult to separate is solved through selective leaching, valuable elements such as antimony, arsenic and sulphur are comprehensively recycled, and the recovery rate of gold and silver is also increased. According to the technology, raw material adaptability is high, the technology process is short, and energy consumption is low.
Owner:BEIJING GENERAL RES INST OF MINING & METALLURGY

Composite developing thermosensitive gel embolizing agent as well as preparation method and application thereof

The invention relates to a composite developing thermosensitive gel embolizing agent as well as a preparation method and application thereof. The preparation method comprises the following steps: firstly, preparing a mixed aqueous solution of an anticancer active substance, a thermosensitive material and a developing agent into composite developing thermosensitive gel; secondly, forming a composite developing thermosensitive gel embolizing agent by the composite developing thermosensitive gel and a coagulant on the scene, wherein the thermosensitive material is hydroxyl C1-4 alkyl cellulose, Pluronic, alginate or a mixture of the substances; the anticancer active substance is arsenic trioxide, docetaxel, cisplatin, carboplatin, nedaplatin, oxaliplatin, lobaplatin, miriplatin, siRNA or a mixture of the substances; the developing agent is a water-soluble developing agent of iodixanol, ioversol or iohexol and the like. The preparation method disclosed by the invention is simple and convenient, is suitable for industrial large-scale production, is particularly suitable for preparing an embolizing agent which is biodegradable and good in biocompatibility and is used for hemorrhagic diseases, and is especially suitable for preparing the composite developing thermosensitive gel embolizing agent for treating liver cancer, kidney cancer, lung cancer, prostate cancer, uterine myoma or splenic tumor and the like.
Owner:苏州申润医疗科技有限公司 +1

Method for extracting arsenic trioxide from roasting dust of arsenic-containing gold concentrate powder

The invention discloses a method for extracting arsenic trioxide from gold concentrate powder roasted fume containing arsenic. The method adopts a staged gradually-heating purification process and a quenching extraction process. The purification process is to volatilize impurities with low melting points in materials under the condition of different temperatures. The purified materials are insulated at a temperature of between 500 and 550 DEG C for more than 150 minutes, so that the arsenic is oxidized into arsenic trioxide gas; the gas is purified through a cyclone dust collector and an electrostatic precipitator in sequence; the purified high-temperature arsenic trioxide gas directly enters a quenching tower of which the temperature is between 120 and 140 DEG C to be crystallized into arsenic trioxide microparticles; and powdery arsenic trioxide collected by a bag arsenic collector is outputted via a scraper conveyor. The method has the advantages that the process procedure is arranged reasonably, controllably and stably, and the rate of extracting the arsenic trioxide from fume is high, and the purity of the extracted arsenic product is high, and the method well solves the problem of arsenic pollution in the gold smelting industry.
Owner:JIANGSU KANGJIE ENVIRONMENT ENG

Iodide ion detection reagent based on iodide catalyzed hydrazine-[oxidant-Ferroin reagent] and iodide ion detection method

The invention discloses an iodide ion detection reagent based on iodide catalyzed hydrazine-[oxidant-Ferroin reagent] and an iodide ion detection method. In an acid medium, a tetravalent cerium solution or potassium permanganate solution is used for oxidizing an orange red Ferroin reagent solution into a blue solution in an acid medium, and a hydrazine saline solution is added to enable the blue solution to generate a reaction that blue is slowly faded to be turned into orange red; iodine has a sensitive oxidizing effect for the reaction, the higher the iodine concentration is, the higher thereaction speed is, a proportional relation is formed between the iodine concentration and the luminance value, and the iodine content of a sample can be calculated by an iodine standard curve. The detection result can be consistent to the result of the iodine tested by adopting a classical arsenic-cerium catalytic photometric method, and the use of a virulent hard-to-purchase arsenic trioxide reagent in the classical arsenic-cerium catalytic photometric method is avoided. The detection method has the advantages of being simple and convenient, rapid, specific, sensitive, accurate and the like,is expected to be widely applied to related fields needing to detect the iodine content of the sample, and especially is applied to urine iodine and water iodine detection in the fields of sanitary inspection and medical technology.
Owner:XIAMEN CENT FOR DISEASE CONTROL & PREVENTION

Arsenic-trioxide-carrying pH-responsive mesoporous silica nanoparticle and preparation method thereof

The invention discloses an arsenic-trioxide-carrying pH-responsive mesoporous silica nanoparticle and a preparation method thereof. The preparation method of the arsenic-trioxide-carrying pH-responsive mesoporous silica nanoparticle mainly comprises the following steps: preparing amino modified mesoporous silica by adopting a coprecipitation method, and loading conjugate acid and base ATO and PAA through electrostatic adsorption for preparing PAA-ATO-MSNs. The prepared PAA-ATO-MSNs are circular or quasi-circular in appearance under a transmission electron microscope, average particle size is (158.6+ / -1.32)nm, Zeta potential is (-28.40+ / -0.34)mV, and encapsulation efficiency and drug loading rate are (40.95+ / -3.21)% and (11.42+ / -1.75)% respectively; in vitro drug release is pH-responsive, and accumulated release amount is increased along with reduction of pH value; pharmacokinetic study shows that compared with ATO-Sol and ATO-MSNs, t1 / 2beta of PAA-ATO-MSNs is obviously prolonged and AUC is obviously increased (P is less than 0.01); and PAA-ATO-MSNs in vitro drug release has obvious pH responsiveness and sustained release property, in vivo pharmacokinetic behaviours of a rat can be obviously improved, and the arsenic-trioxide-carrying pH-responsive mesoporous silica nanoparticle carrier can serve as an ATO tumour-targeted drug delivery system and has a good application prospect.
Owner:ZHEJIANG CHINESE MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products